According to Amanda, both children have faced challenges in adapting. Peyton is still grappling with the loss of another ...

Ken Kato, MD, PhD, and Harry H. Yoon, MD, MHS, discussed the recent FDA approval of tislelizumab in the first line for patients with esophageal squamous cell carcinoma.

Researchers at Case Western Reserve University have discovered molecules that present the potential to drive the development ...

A Midtown-based diagnostics company raised capital in a deal to advance its novel approach to screening for the risk factors ...

The ACG has revised its guidance for gastric premalignant conditions, such as atrophic gastritis, gastric intestinal ...

Esophageal squamous cell carcinoma accounts for approximately 90% of all esophageal cancer cases. Projections estimate that ...

Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that ...

The FDA approved Tevimbra with chemotherapy for adults with unresectable or metastatic esophageal squamous cell carcinoma ...

With further testing, discovery may offer new target for early detection and treatmentResearchers at Case Western Reserve ...